Effect of intravenous immunoglobulin on reduction of sepsis mortality

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138710301378N4

Enrollment

Registered

2009-03-18

Start date

2002-07-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonate infection. Bacterial sepsis of newborn, unspecified

Interventions

Intervention 1: intervention group: 1000mg/K IVIG single dose + Routine antibiotic therapy. Intervention 2: control group: Routine antibiotic therapy.

Treatment - Drugs

intervention group: 1000mg/K IVIG single dose + Routine antibiotic therapy

control group: Routine antibiotic therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Preterm infants that have birth weight less than 2500gr with positive blood culture and admitted in NICU of Emamreza hospital. Exclusion criteria: Congenital anomaly, severe pulmonary problem or ventilation, cardiac disease, nephrologic problem

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mortality. Timepoint: the end of study. Method of measurement: mortality rate.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ahmadshah Farhat

Neonatal Research Center

farhata@mums.ac.ir+98 51 1852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026